Embla Medical hf (EMBLA)

Currency in DKK
37.10
+0.90(+2.49%)
Real-time Data·

EMBLA Earnings

Latest Release
Oct 31, 2025
EPS / Forecast
0.06 / 0.0535
Revenue / Forecast
237.00M / 233.50M
EPS Revisions
Last 90 days
Release Date
Period End
EPS
/Forecast
Revenue
/Forecast
EPS Surprise %
Revenue Surprise %
Reaction
12/2025--/0.059--/258.13M----Free Sign Up
09/20250.06/0.054237M/233.5M+12.15%+1.5%Free Sign Up
06/20250.05/0.05232.42M/234.43M+0.6%-0.86%Free Sign Up
03/20250.03/--203M/------Free Sign Up
12/20240.042/0.05225M/226.04M-17%-0.46%Free Sign Up
09/20240.051/0.041214M/212.18M+22.28%+0.86%Free Sign Up
06/20240.047/0.05217M/217M-6%0%Free Sign Up
03/20240.02/0.02199.95M/199.95M-2.5%0%Free Sign Up
12/20230.046/0.05210.2M/210.12M-9%+0.04%Free Sign Up
09/20230.033/0.03192.92M/192.92M+10%0%Free Sign Up

All numbers in USD

Embla Medical hf Earnings Call Summary for Q3/2025

  • Q3 revenue reached $237M, up 11% YoY, with 7% organic growth; EPS beat expectations, driving stock up 3.17% to $32.50
  • Prosthetics and orthotics segments saw 13% organic growth, boosted by ArtiseiQ and ICON launches; APAC and EMEA sales increased
  • Full-year guidance maintained at 5-6% organic growth with 20-21% EBITDA margin; H2 expected to be stronger
  • Potential U.S. trade restrictions could impact future earnings; company exploring U.S. production options to mitigate tariffs
  • CEO confident in long-term strategy despite challenges in bracing segment; aims to return to market growth rates by 2026
Last Updated: 21/10/2025, 09:32
Read Full Transcript

FAQ

What Is Embla Medical hf's Earnings Per Share (TTM)?

The Embla Medical hf EPS (TTM) is 0.18.

When Is The Next Embla Medical hf Earnings Date?

Embla Medical hf will release its next earnings report on 02 Feb 2026.

What Is Embla Medical hf’s Revenue Forecasts For Upcoming Quarters?

Embla Medical hf’s revenue forecast is 258.13M.

How Did Embla Medical hf React to the Company's Latest Earnings Report?

Embla Medical hf reported a +12.15%% EPS surprise and a +1.5%% revenue surprise, comparing the latest report against analyst forecasts. The stock price changed by 2.10%%, reflecting the market's response to the earnings results.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.